Non-pharmacologic therapy of arterial hypertension

Česká verzia

Authors: H. Rosolová
Authors place of work: II. interní kliniky LF UK a FN v Plzni ; Centrum preventivní kardiologie
Published in the journal: Kardiol Rev Int Med 2006, 8(1-2): 44-46
Category: Editorial

Summary

Non-pharmacologic therapy, i.e. life-style modification in terms of non-smoking, low-energy diet and regular exercising, is an integral part of arterial hypertension therapy. As such, it has to be started early and very intensively. Patients should be advised on a desirable percentage of individual diet components and appropriate food, as well as on risk factors of smoking and excessive alcohol consumption. Also, non-pharmacological therapy should include stress compensation and prevention of depressive disorders, as chronic stress demonstrably increases the cardiovascular risk.

Keywords:
non-smoking – well-balanced diet – hypertension – exercising – stress compensation

Zdroje

1. Cífková R, Býma S, Rosolová H et al. Prevence kardiovaskulárních onemocnění v dospělém věku. Společné doporučení českých odborných společností. Vniř Lék 2005; 51: 1021-1036.

2. Van Melle JP et al. Prognostic association of depression following MI with mortality and CV events: a meta-analysis. Psychosom Med 2004; 66: 814-822.

3. Facchini FS, Hollenbeck CB, Jeppesen J et al. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-1130.

4. Králíková E, Býma S, Rosolová H et al. Doporučení pro léčbu závislosti na tabáku. Čas Lék Čes 2005; 144: 327-333.

5. Garg A, Bantle JP, Henry RR et al. Effects of varying carbohydrate content of diet in patients with non-insulin dependent diabetes. JAMA 1994; 271: 1421-1428.

6. Sacks FM, Svetkey LP, Vollmer WM et al for the DASH – Podium Collaborative Research Group. Effects on blood pressure of reduced dietary podium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344: 3-10.

7. Chobanian AV, Bakfiš GL, Blafl HR et al. NHLBI Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The 7th Report of the Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.

8. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990; 31: 1149-1172.

9. Klatsky AL. Moderate drinking and reduced risk of heart disease. Alcohol Res Health 1999; 23: 15-24.

10. Rosolová H, Šimon J, Šefrna F. Impact of cardiovascular risk factors on morbidity and mortality in Czech middle-aged men: Pilsen Longitudinal Study. Cardiology 1994; 85: 61-68.

11. Petrlova B, Rosolova H, Hess Z, Podlipny J, Simon J. Depressive Disorders and the Metabolic Syndrome of Insulin Resistance. Semin Vasc Med 2004; 4: 161-165.

12. Hess Z, Podlipny J, Rosolova H et al. Depression as one of Risk Factors of the Metabolic Syndrome. In: Progress in Metabolic Syndrome Research. New York: Nova Science Publishers 2006 (přijato do tisku).

13. Bonnet F, Irving K, Terra JL et al. Depressive symptoms are associated with unhealthy lifestyles in hypertensive patiens with metabolic syndrome. J Hypertens 2005; 23: 611-617.